Cargando…

Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation

The 78-kDa glucose-regulated protein (Grp78) is stress-inducible chaperone that mostly reside in the endoplasmic reticulum. Grp78 has been described to be released at times of cellular stress and as having extracellular properties that are anti-inflammatory or favor the resolution of inflammation. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Muyang, Zhang, Fan, Qin, Kai, Wu, Min, Li, Heli, Zhu, Huifen, Ning, Qin, Lei, Ping, Shen, Guanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131008/
https://www.ncbi.nlm.nih.gov/pubmed/27990144
http://dx.doi.org/10.3389/fimmu.2016.00552
_version_ 1782470813994188800
author Yang, Muyang
Zhang, Fan
Qin, Kai
Wu, Min
Li, Heli
Zhu, Huifen
Ning, Qin
Lei, Ping
Shen, Guanxin
author_facet Yang, Muyang
Zhang, Fan
Qin, Kai
Wu, Min
Li, Heli
Zhu, Huifen
Ning, Qin
Lei, Ping
Shen, Guanxin
author_sort Yang, Muyang
collection PubMed
description The 78-kDa glucose-regulated protein (Grp78) is stress-inducible chaperone that mostly reside in the endoplasmic reticulum. Grp78 has been described to be released at times of cellular stress and as having extracellular properties that are anti-inflammatory or favor the resolution of inflammation. As antigen-presenting cells (APCs) play a critical role in both the priming of adaptive immune responses and the induction of self-tolerance, herein, we investigated the effect of Grp78 on the maturation of murine myeloid APCs (CD11c(+) cells). Results showed that CD11c(+) cells could be bound by AF488-labeled Grp78 and that Grp78 treatment induced a tolerogenic phenotype comparable to immature cells. Furthermore, when exposed to lipopolysaccharide, Grp78-treated CD11c(+) cells (DC(Grp78)) did not adopt a mature dendritic cell phenotype. DC(Grp78)-primed T cells exhibited reduced proliferation along with a concomitant expansion of CD4(+)CD25(+)FoxP3(+) cells in pancreaticoduodenal lymph nodes and induction of T cell apoptosis in vitro and ex vivo. The above work suggests that Grp78 is an immunomodulatory molecule that could aid resolution of inflammation. It may thus contribute to induce durable tolerance to be of potential therapeutic benefit in transplanted allogeneic grafts and autoimmune diseases such as type I diabetes.
format Online
Article
Text
id pubmed-5131008
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-51310082016-12-16 Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation Yang, Muyang Zhang, Fan Qin, Kai Wu, Min Li, Heli Zhu, Huifen Ning, Qin Lei, Ping Shen, Guanxin Front Immunol Immunology The 78-kDa glucose-regulated protein (Grp78) is stress-inducible chaperone that mostly reside in the endoplasmic reticulum. Grp78 has been described to be released at times of cellular stress and as having extracellular properties that are anti-inflammatory or favor the resolution of inflammation. As antigen-presenting cells (APCs) play a critical role in both the priming of adaptive immune responses and the induction of self-tolerance, herein, we investigated the effect of Grp78 on the maturation of murine myeloid APCs (CD11c(+) cells). Results showed that CD11c(+) cells could be bound by AF488-labeled Grp78 and that Grp78 treatment induced a tolerogenic phenotype comparable to immature cells. Furthermore, when exposed to lipopolysaccharide, Grp78-treated CD11c(+) cells (DC(Grp78)) did not adopt a mature dendritic cell phenotype. DC(Grp78)-primed T cells exhibited reduced proliferation along with a concomitant expansion of CD4(+)CD25(+)FoxP3(+) cells in pancreaticoduodenal lymph nodes and induction of T cell apoptosis in vitro and ex vivo. The above work suggests that Grp78 is an immunomodulatory molecule that could aid resolution of inflammation. It may thus contribute to induce durable tolerance to be of potential therapeutic benefit in transplanted allogeneic grafts and autoimmune diseases such as type I diabetes. Frontiers Media S.A. 2016-12-01 /pmc/articles/PMC5131008/ /pubmed/27990144 http://dx.doi.org/10.3389/fimmu.2016.00552 Text en Copyright © 2016 Yang, Zhang, Qin, Wu, Li, Zhu, Ning, Lei and Shen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yang, Muyang
Zhang, Fan
Qin, Kai
Wu, Min
Li, Heli
Zhu, Huifen
Ning, Qin
Lei, Ping
Shen, Guanxin
Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation
title Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation
title_full Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation
title_fullStr Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation
title_full_unstemmed Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation
title_short Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation
title_sort glucose-regulated protein 78-induced myeloid antigen-presenting cells maintained tolerogenic signature upon lps stimulation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131008/
https://www.ncbi.nlm.nih.gov/pubmed/27990144
http://dx.doi.org/10.3389/fimmu.2016.00552
work_keys_str_mv AT yangmuyang glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation
AT zhangfan glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation
AT qinkai glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation
AT wumin glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation
AT liheli glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation
AT zhuhuifen glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation
AT ningqin glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation
AT leiping glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation
AT shenguanxin glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation